SOX17 and esophageal squamous cell carcinoma: Our study provides new evidence that tumor suppressor SOX17 transcriptionally inactivates DNA repair and DNA damage responsive genes to enhance sensitivity to CCRT treatment in ESCC (Fig. 9).